Prevalence of non-alcoholic fatty liver disease and its associated factors in individuals with type 1 diabetes: a cross-sectional study in a tertiary care center in Brazil
Open Access
- 19 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetology & Metabolic Syndrome
- Vol. 13 (1), 1-11
- https://doi.org/10.1186/s13098-021-00649-0
Abstract
Data on non-alcoholic fatty liver disease (NAFLD) in individuals with type 1 diabetes (T1D) is controversial and so far, there are no published data on the Brazilian population. We investigated the prevalence of steatosis and hepatic fibrosis in a population with T1D from a tertiary care center in Brazil and its associated factors. Ninety-five participants with T1D, aged 39 ± 13 years, with disease duration of 21 ± 9 years, being 55 (57.9%) females, from a university hospital in Rio de Janeiro, were screened for NAFLD with hepatic ultrasound (US) and transient elastography (TE). Prevalence of steatosis was, respectively, 12.6% and 16.8% when US and TE were used for diagnosis of NAFLD. Fibrosis was present in 8.4% of participants. A total of 31.6% of participants had at least one of the hepatic exams altered, which was associated with higher body mass index, waist circumference, hip circumference and waist-to-hip ratio,, presence of metabolic syndrome and higher triglycerides levels, even within the normal range. After multivariate analysis, presence of steatosis was only associated with metabolic syndrome and its component, triglycerides. In our study, prevalence of NAFLD in ultrasound approximates the one found with TE. Fibrosis was not frequent. Screening should be reserved for participants with T1D and metabolic syndrome, as this was the main factor associated with NAFLD. Triglycerides levels were the only component of metabolic syndrome associated with steatosis. Further studies are necessary to determine the best screening strategy for NAFLD in individuals with T1D. Also, predisposing factors for development in fibrosis in T1D should be further explored in prospective studies.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (563753/2010-2)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E 26/110.170/2013)
This publication has 33 references indexed in Scilit:
- Liver Fat Content and Hepatic Insulin Sensitivity in Overweight Patients With Type 1 DiabetesJournal of Clinical Endocrinology & Metabolism, 2015
- Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastographyLiver International, 2012
- Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non‐alcoholic fatty liverDiabetic Medicine, 2011
- Hepatic Steatosis in Type 1 DiabetesThe Review of Diabetic Studies, 2011
- Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetesJournal of Hepatology, 2010
- Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patientsDiabetologia, 2010
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver diseaseJournal of Hepatology, 2009
- Non-invasive means of measuring hepatic fat contentWorld Journal of Gastroenterology, 2008
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Gestational diabetes: after the ACHOIS trialDiabetic Medicine, 2006